CARRIE LOPER: Open Payments
NPI 1306325428 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 31 payments from 12 companies in 2025. Trend: 2023 $278 · 2024 $1,239 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 7 | $259 |
| CVRx, Inc. | 3 | $232 |
| Ancora Heart, Inc. | 1 | $164 |
| ABIOMED | 1 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $115 |
| PFIZER INC. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| BridgeBio Pharma, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $38 |
Products named: AMVUTTRA, Barostim Neo System, AccuCinch, FARXIGA, VYNDAQEL, Kerendia, Attruby, JARDIANCE.
Industry payments across GA — which companies pay providers there.
